D. Nanchen

Discipline

Psychologie (6) Sociologie (2) Education (2) Gestion et management (1) Economies et finances (1)

Type de document

Articles (48) Recensions (3) Mémoires, Thèses et HDR (1)

Co-auteur

Date

Source

Mot-clé

Patients (29) Patients (26) Human beings (25) Risk (24) risque (23) cohorte (23) âge (20) Older people (20) Age (20) Age (20) Prevention (16) Year (16) Ci (Chinese poetry) (16) Syndromes (16) maladie cardiovasculaire (15) Risk factors (14) association (13) Treatment (13) Social groups (13) Example (11) mortalité (10) modèle (10) Mortality (10) Control (10) Mortality (10) Myocardial infarction (10) Cholesterol (10) Models (10) thérapie (9) Smoking cessation (9)

Documents écrit par D. Nanchen (49) | parle de D. Nanchen (0)

Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
B. Delabays et al. (30 nov. 2023)
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities.
A. Denegri et al. (1 juil. 2023)
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
S. Kraler et al.
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study.
K.K. Ray et al.
Une histoire familiale d’hypercholestérolémie – le rôle de la génétique [A Family History of Hypercholesterolemia - the Role of Genetics]
C. Podmore et al. (2023)
Smoking Cessation in People With and Without Diabetes After Acute Coronary Syndrome.
L. Clement et al. (1 janv. 2023)
Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey.
C.V. Eisenring et al.
Smoking cessation and depression after acute coronary syndrome.
K. Krasieva et al.
Cohort Profile: The Lausanne cohort 65+ (Lc65+).
Y. Henchoz et al. (10 août 2022)
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study.
L. Gilgien-Dénéréaz et al. (18 juil. 2022)
Dépistage génétique en cascade de l’hypercholestérolémie familiale - Une nouvelle opportunité pour la prévention cardiovasculaire [Cascade genetic testing of familial hypercholesterolemia A new opportunity for prevention]
A. Butty et al. (9 mars 2022)
Recommandations européennes 2021 pour la prévention cardiovasculaire : nouveautés [European guidelines 2021 for the cardiovascular prevention: new concepts]
E. Vasilakou et al. (9 mars 2022)
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland.
I. Worni-Schudel et al.
Conseils pour une alimentation saine : perspectives cliniques et communautaires [Healthy eating counseling : Clinical and community perspectives]
D. Nanchen et al. (10 nov. 2021)
Trois approches de communication médecin-patient et prévention : quel modèle pour quelle situation ? [Three approaches to doctor-patient communication and prevention : Which model for which situation ?]
I. Habfast-Robertson et al. (10 nov. 2021)
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
R. Klingenberg et al. (19 oct. 2021)
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
T. Mahendiran et al.
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI study.
K.K. Ray et al.
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection.
A. Forrer et al. (30 mars 2021)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
R. Klingenberg et al.
Trends in Physical and Cognitive Performance Among Community-Dwelling Older Adults in Switzerland.
Y. Henchoz et al. (13 nov. 2020)
[Conseil en activité physique] : Réponse
J.N. Spring et al. (10 juin 2020)
Controverses sur le dépistage et la prise en charge des dyslipidémies familiales en 2020 [Controversies concerning screening and treatment of primary dyslipidemias in 2020]
L. Bretagne et al. (4 mars 2020)
Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?]
G. Ravach et al. (4 mars 2020)
Nouvelles recommandations européennes et américaines pour les dyslipidémies : similitudes et différences [New European and American guidelines on the management of blood cholesterol : similarities and differences]
A. Butty et al. (4 mars 2020)

next